|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0012634,
umls-concept:C0013216,
umls-concept:C0034656,
umls-concept:C0205087,
umls-concept:C0282460,
umls-concept:C0439801,
umls-concept:C0679729,
umls-concept:C0684249,
umls-concept:C0817096,
umls-concept:C1518578,
umls-concept:C1522449,
umls-concept:C1707455
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2001-11-7
|
|
pubmed:abstractText |
Concurrent platinum etoposide chemotherapy given in combination with hyperfractionated thoracic radiation therapy (HTRT) in limited disease (LD) small cell lung cancer (SCLC) is associated with a high response rate and significant prolongation of survival. Given these results, the Hellenic Cooperative Oncology Group (HeCOG) performed a multicenter randomized phase II study in patients with LD SCLC to evaluate the timing of HTRT (early vs. late) when given concurrently with chemotherapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0923-7534
|
|
pubmed:author |
pubmed-author:BriassoulisEE,
pubmed-author:FountzilasGG,
pubmed-author:KalofonosH PHP,
pubmed-author:KardamakisDD,
pubmed-author:KosmidisPP,
pubmed-author:KouvatseasGG,
pubmed-author:PanoussakiEE,
pubmed-author:PavlidisNN,
pubmed-author:SamantasEE,
pubmed-author:SkarlosD VDV,
pubmed-author:TsavdaridisDD,
pubmed-author:TsekerisPP,
pubmed-author:TsiakopoulosEE,
pubmed-author:TzitzikasJJ,
pubmed-author:ZamboglouNN
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
12
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1231-8
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:11697833-Adult,
pubmed-meshheading:11697833-Aged,
pubmed-meshheading:11697833-Anemia,
pubmed-meshheading:11697833-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:11697833-Carboplatin,
pubmed-meshheading:11697833-Carcinoma, Small Cell,
pubmed-meshheading:11697833-Combined Modality Therapy,
pubmed-meshheading:11697833-Disease Progression,
pubmed-meshheading:11697833-Dose Fractionation,
pubmed-meshheading:11697833-Etoposide,
pubmed-meshheading:11697833-Female,
pubmed-meshheading:11697833-Humans,
pubmed-meshheading:11697833-Infusions, Intravenous,
pubmed-meshheading:11697833-Lung Neoplasms,
pubmed-meshheading:11697833-Male,
pubmed-meshheading:11697833-Middle Aged,
pubmed-meshheading:11697833-Neutropenia,
pubmed-meshheading:11697833-Survival Analysis,
pubmed-meshheading:11697833-Thrombocytopenia,
pubmed-meshheading:11697833-Treatment Outcome
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Randomized comparison of early versus late hyperfractionated thoracic irradiation concurrently with chemotherapy in limited disease small-cell lung cancer: a randomized phase II study of the Hellenic Cooperative Oncology Group (HeCOG).
|
|
pubmed:affiliation |
Athens Medical Center, Greece. hecogoff@otenet.gr
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Multicenter Study,
Clinical Trial, Phase II
|
